# A Study to Compare to PK Characteristics and Safety Profiles Between PA-111 and PA-111A

> **NCT06932705** · PHASE1 · RECRUITING · sponsor: **Addpharma Inc.** · enrollment: 48 (estimated)

## Conditions studied

- Mixed Dyslipidemia

## Interventions

- **DRUG:** PA-111
- **DRUG:** PA-111A

## Key facts

- **NCT ID:** NCT06932705
- **Lead sponsor:** Addpharma Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-04
- **Primary completion:** 2025-05
- **Final completion:** 2025-05
- **Target enrollment:** 48 (ESTIMATED)
- **Last updated:** 2025-04-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06932705

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06932705, "A Study to Compare to PK Characteristics and Safety Profiles Between PA-111 and PA-111A". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT06932705. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*